Lori Sakoda to Lung Neoplasms
This is a "connection" page, showing publications Lori Sakoda has written about Lung Neoplasms.
Connection Strength
4.844
-
Clinical Adjuncts to Lung Cancer Screening: A Narrative Review. Thorac Surg Clin. 2023 Nov; 33(4):421-432.
Score: 0.630
-
Facilitating Adherence to Annual Screening for Lung Cancer: Are Program-Level Interventions Enough? Chest. 2022 07; 162(1):8-10.
Score: 0.594
-
Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings. JAMA Netw Open. 2021 04 01; 4(4):e218559.
Score: 0.545
-
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
Score: 0.540
-
Effectiveness of a Patient Education Class to Enhance Knowledge about Lung Cancer Screening: a Quality Improvement Evaluation. J Cancer Educ. 2020 10; 35(5):897-904.
Score: 0.526
-
Standardized Reporting and Management of Suspicious Findings on Chest CT Imaging Is Associated With Improved Lung Cancer Diagnosis in an Observational Study. Chest. 2020 11; 158(5):2211-2220.
Score: 0.516
-
Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
Score: 0.355
-
Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control. 2011 Mar; 22(3):449-61.
Score: 0.268
-
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 2022 08; 54(8):1167-1177.
Score: 0.149
-
An Intervention to Tag Findings Suspicious for Lung Cancer on Chest Computed Tomography Has Good Sensitivity and Number Needed to Diagnose. Perm J. 2021 May 12; 25.
Score: 0.137
-
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 10 01; 202(7):e95-e112.
Score: 0.132
-
COPD and lung cancer incidence in the Women's Health Initiative Observational Study: A brief report. Lung Cancer. 2020 03; 141:78-81.
Score: 0.125
-
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer. JCO Clin Cancer Inform. 2019 07; 3:1-15.
Score: 0.121
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.108
-
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
Score: 0.099